{"slideshow_credits": null, "snippet": "The bidding-war triumph is a much-needed win for Valeant after it failed last year in its pursuit of Allergan, the maker of Botox.", "abstract": "Valeant Pharmaceuticals International says it will pay $11 billion, or $173 a share, for Salix Pharmaceuticaals, up from $158 a share; Endo International withdraws its $11.2 billion bid to buy Salix.", "section_name": "Business Day", "print_page": "4", "document_type": "article", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://www.nytimes.com/2015/03/17/business/dealbook/valeant-raises-offer-for-salix.html", "lead_paragraph": "The bidding-war triumph is a much-needed win for Valeant after it failed last year in its pursuit of Allergan, the maker of Botox.", "headline": {"main": "Raising Its Bid, Valeant Cinches a Deal ", "print_headline": "Raising Its Bid, Valeant Cinches a Deal"}, "_id": "5506cab438f0d85e90e00274", "word_count": "668", "multimedia": [{"height": 126, "url": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 424, "url": "images/2015/03/17/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/03/17/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "424"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/03/17/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-03-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Endo International PLC", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5"}, {"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}